These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7853673)

  • 1. [Re-evaluation of current antimicrobials. Series 19: ceftriaxone. Discussion].
    Jpn J Antibiot; 1994 Nov; 47(11):1433-40. PubMed ID: 7853673
    [No Abstract]   [Full Text] [Related]  

  • 2. [Re-evaluation of current antimicrobials. Series 20: netilmicin sulfate. Discussion].
    Jpn J Antibiot; 1994 Nov; 47(11):1441-8. PubMed ID: 7853674
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of cephalosporines III generation with varying biliary excretion on fecal flora and emergence of resistant bacteria during and after cessation of therapy.
    Guggenbichler JP; Allerberger FJ; Dierich M
    Padiatr Padol; 1986; 21(4):335-42. PubMed ID: 3562044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of ceftriaxone in the treatment of severe infections in hospitalized patients.
    Alexopoulos E; Anassis P; Hadjidimitrou C; Papadimitriou M
    Chemioterapia; 1987 Jun; 6(2 Suppl):380-1. PubMed ID: 3509452
    [No Abstract]   [Full Text] [Related]  

  • 5. [New antimicrobial agent series XVIII: Ceftriaxone].
    Kobayashi H
    Jpn J Antibiot; 1986 Dec; 39(12):3129-39. PubMed ID: 3550169
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ceftriaxone].
    Friis H; Moesgaard F
    Ugeskr Laeger; 1987 Oct; 149(44):2991-3. PubMed ID: 3433495
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reevaluation of current antimicrobials. Series 15: aztreonam. Discussion].
    Jpn J Antibiot; 1994 Sep; 47(9):1123-30. PubMed ID: 7990254
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reevaluation of current antimicrobials. Series 14: sulbactam sodium/cefoperazone sodium. Discussion].
    Jpn J Antibiot; 1994 Sep; 47(9):1115-22. PubMed ID: 7990253
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reevaluation of current antimicrobials. Cefpodoxime proxetil. Discussion].
    Jpn J Antibiot; 1995 Feb; 48(2):183-90. PubMed ID: 7745807
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bacteriological, pharmacokinetic and clinical evaluations of ceftriaxone in the pediatric field. Pediatric study group of ceftriaxone].
    Fujii R; Meguro H; Arimasu O; Tagaya M; Fujita K; Sakata H; Yoshioka H; Maruyama S; Sanae N; Nagamatsu I
    Jpn J Antibiot; 1986 Aug; 39(8):1988-2008. PubMed ID: 3540338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of ceftriaxone in the pediatric field].
    Hoshina H; Hirosawa H; Mikuni K; Ichihashi H
    Jpn J Antibiot; 1984 Nov; 37(11):2027-33. PubMed ID: 6098699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and pharmacokinetic study of ceftriaxone in pediatric bacterial infections].
    Meguro H; Nonaka C; Kawaoi T; Takahashi S; Fujii R; Arimasu O
    Jpn J Antibiot; 1984 Nov; 37(11):2049-59. PubMed ID: 6098701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reevaluation of current antimicrobials. cefdinir (discussion)].
    Jpn J Antibiot; 1995 Jun; 48(6):733-40. PubMed ID: 7666577
    [No Abstract]   [Full Text] [Related]  

  • 14. Indications for a ceftriaxone dosing regimen in Japanese paediatric patients using population pharmacokinetic/pharmacodynamic analysis and simulation.
    Iida S; Kawanishi T; Hayashi M
    J Pharm Pharmacol; 2011 Jan; 63(1):65-72. PubMed ID: 21155817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reevaluation of current antimicrobials. Ciprofloxacin. Discussion].
    Jpn J Antibiot; 1995 Feb; 48(2):175-82. PubMed ID: 7745806
    [No Abstract]   [Full Text] [Related]  

  • 16. [Reevaluation of current antimicrobials: cefodizime. Discussion].
    Matsumoto K; Nagayama A
    Jpn J Antibiot; 1995 Mar; 48(3):303-10. PubMed ID: 7752447
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical and pharmacokinetic study of ceftriaxone in the treatment of 14 episodes of ascitic fluid infection].
    Ducroix JP; Guerlin M; Hary L; Smail A; Denamur E; Eb F; Andrejak M; Baillet J
    Pathol Biol (Paris); 1988 Oct; 36(8):1007-10. PubMed ID: 3059283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Level of evidence for therapeutic drug monitoring of ceftriaxone].
    Dailly E; Verdier MC; Deslandes G; Bouquié R; Tribut O; Bentué-Ferrer D
    Therapie; 2012; 67(2):145-9. PubMed ID: 22850101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen.
    Bradsher RW; Snow RM
    Am J Med; 1984 Oct; 77(4C):63-7. PubMed ID: 6093522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term administration of ceftriaxone (Ro 13-9904) to complicated urinary tract infections].
    Oishi K; Kawakita M; Hida S; Higashi Y; Yamauchi T; Yoshida O
    Hinyokika Kiyo; 1985 Apr; 31(4):711-21. PubMed ID: 4036746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.